1. Mesenchymal stem cells moderate immune response of type 1 diabetes
   Junbi Xv et al, 2017, Cell Tissue Res CrossRef
2. Discarded Wharton jelly of the human umbilical cord: a viable source for mesenchymal stromal cells
   Nate Watson et al, 2015, Cytotherapy CrossRef
3. Characteristics of human umbilical cord mesenchymal stem cells during ex vivo expansion
   SHENGYING LI et al, 2015 CrossRef
4. Transplantation of betatrophin-expressing adipose-derived mesenchymal stem cells induces β-cell proliferation in diabetic mice
   Liang-Liang Sun et al, 2017 CrossRef
5. Transplantation routes affect the efficacy of human umbilical cord mesenchymal stem cells in a rat GDM model
   Dan Wu et al, 2017, Clinica Chimica Acta CrossRef
6. The roles of the co-culture of mEScs with pancreatic islets and liver stromal cells in the differentiation of definitive endoderm cells
   Hoveizi Elham et al, 2017, Biologicals CrossRef
7. Functional collagen conduits combined with human mesenchymal stem cells promote regeneration after sciatic nerve transection in dogs
   Yi Cui et al, 2018, J Tissue Eng Regen Med CrossRef
8. Differentiation of equine bone marrow derived mesenchymal stem cells increases the expression of immunogenic genes
   Laura Barrachina et al, 2018, Veterinary Immunology and Immunopathology CrossRef
9. Human umbilical cord mesenchymal stem cell transplantation restores damaged ovaries
   Shao-Fang Zhu et al, 2015, J. Cell. Mol. Med. CrossRef
10. Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice
    Gianluca Moroncini et al, 2018, PLoS ONE CrossRef
11. Priming Equine Bone Marrow-Derived Mesenchymal Stem Cells with Proinflammatory Cytokines: Implications in Immunomodulation–Immunogenicity Balance, Cell Viability, and Differentiation Potential
    Laura Barrachina et al, 2017, Stem Cells and Development CrossRef
12. Extracellular vesicles from human umbilical cord mesenchymal stem cells improve nerve regeneration after sciatic nerve transection in rats
    Yongbin Ma et al, 2019, J Cell Mol Med CrossRef
13. Wharton’s Jelly Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes
    Rita Anzalone et al, 2014 CrossRef
14. Wharton’s Jelly Stem Cells
    Marina Bastawrous et al, 2016 CrossRef
15. Clinicopathological studies on the use of laser-activated adipose-derived stromal vascular fraction in treatment of streptozotocin-induced diabetes in rats
    Safaa Y. Sayed et al, 2019, Comp Clin Pathol CrossRef
16. Poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) scaffolds coated with PhaP-RGD fusion protein promotes the proliferation and chondrogenic differentiation of human umbilical cord mesenchymal stem cells in vitro
    Xiaoli Li et al, 2015, J. Biomed. Mater. Res. CrossRef
17. Multi-Lineage Differentiation of Human Umbilical Cord Wharton’s Jelly Mesenchymal Stromal Cells Mediates Changes in the Expression Profile of Stemness Markers
    Hamad Ali et al, 2015, PLoS ONE CrossRef
18. Extrinsic and Intrinsic Mechanisms by Which Mesenchymal Stem Cells Suppress the Immune System
    Vivien J. Coulson-Thomas et al, 2016, The Ocular Surface CrossRef
19. Self-assembled dual-modality contrast agents for non-invasive stem cell tracking via near-infrared fluorescence and magnetic resonance imaging
    Hong Liu et al, 2016, Journal of Colloid and Interface Science CrossRef
20. Characterization of Sox9-overexpressing human umbilical cord blood-derived mesenchymal stem cells-based engineered cartilage bothin vitroandin vivo
    Xiao-Li Li et al, 2017, J. Biomed. Mater. Res. CrossRef
21. Perinatal Mesenchymal Stromal Cells and Their Possible Contribution to Fetal-Maternal Tolerance
    Marta Magatti et al, 2019, Cells CrossRef
22. Cell-based immunomodulatory therapy approaches for type 1 diabetes mellitus
    Labe Black et al, 2019, Drug Discovery Today CrossRef
23. Human umbilical cord mesenchymal stem cells alleviate interstitial fibrosis and cardiac dysfunction in a dilated cardiomyopathy rat model by inhibiting TNF‑α and TGF‑β1/ERK1/2 signaling pathways
    Changyi Zhang et al, 2017, Mol Med Report CrossRef
24. A novel method to isolate mesenchymal stem cells from mouse umbilical cord
    Bin Zhang et al, 2017, Mol Med Report CrossRef
25. Perinatal Cells: A Promising COVID-19 Therapy?
    Andrea Papait et al, 2021, Front. Bioeng. Biotechnol. CrossRef
26. Extracellular Vesicles From Perinatal Cells for Anti-inflammatory Therapy
    Anna Cargnoni et al, 2021, Front. Bioeng. Biotechnol. CrossRef
27. The Role of B Cells in PE Pathophysiology: A Potential Target for Perinatal Cell-Based Therapy?
    Marta Magatti et al, 2021, IJMS CrossRef
28. Human umbilical cord matrix-derived stem cells exert trophic effects on β-cell survival in diabetic rats and isolated islets
    Yunting Zhou et al, 2015 CrossRef
29. Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD
    Judith Derdelinckx et al, 2021, IJMS CrossRef
30. Human umbilical cord-derived mesenchymal stem cells ameliorate psoriasis-like dermatitis by suppressing IL-17-producing γδ T cells
    Youdong Chen et al, 2022, Cell Tissue Res CrossRef
31. Pancreatic transplant surgery and stem cell therapy: Finding the balance between therapeutic advances and ethical principles
    Martina Padovano et al, 2022, WJSC CrossRef
32. Perinatal derivatives: How to best validate their immunomodulatory functions
    Andrea Papait et al, 2022, Front. Bioeng. Biotechnol. CrossRef
33. Perinatal Stem Cell Therapy to Treat Type 1 Diabetes Mellitus: A Never-Say-Die Story of Differentiation and Immunomodulation
    Francesca Paris et al, 2022, IJMS CrossRef
34. Engineered cell-overexpression of circular RNA hybrid hydrogels promotes healing of calvarial defects
    Min Zhang et al, 2022, Biomater. Sci. CrossRef
35. Perspective Chapter: Role of Cytotrophoblast Cells and Placenta-Derived Exosomes in Regulatory B Cell Differentiation and Function during Pregnancy
    Gatien A.G. Lokossou et al, 2023 CrossRef
36. Clinical Trials Targeting Secondary Damage after Traumatic Spinal Cord Injury
    Zin Z. Khaing et al, 2023, IJMS CrossRef
37. Characterization of the Phenotypic Features, Immuno-modulatory Properties and Therapeutic Potentials of Wharton’s Jelly-Derived Mesenchymal Stromal Cells
    Ike dela Peña et al, 2015 CrossRef
38. Wharton’s jelly mesenchymal stem cells: a concise review of their secretome and prospective clinical applications
    Hana Drobiova et al, 2023, Front. Cell Dev. Biol. CrossRef
39. Protein Phosphorylation Mechanism of Mesenchymal Stem Cells in the Treatment of Sepsis: A Systematic Review and Meta-analysis
    Hongwu Wang et al, 2023, CMM CrossRef
40. A GMP-compliant manufacturing method for Wharton’s jelly-derived mesenchymal stromal cells
    Wanglong Chu et al, 2024, Stem Cell Res Ther CrossRef
41. Expert Consensus on the Application of Stem Cells in Psoriasis Research and Clinical Trials
    Ye-Hong Kuang et al, 2024, Aging and disease CrossRef
42. Human mesenchymal stem/stromal cell based-therapy in diabetes mellitus: experimental and clinical perspectives
    Alaa Zeinhom et al, 2024, Stem Cell Res Ther CrossRef